Raltegravir One Thousand Two Hundred vs Darunavir-cb in Immnunosupressed Patients: ROTDIP Study

NCT03842488 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
75
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Collaborators